Many men with benign prostatic hyperplasia (BPH) forego therapy because they are dissatisfied with current treatment options.
While surgical resection and ablation using many different forms of energy remain the reference standard for BPH treatment, many men seek a less invasive technique that will improve symptoms but not risk the complications associated with tissue removal. The Prostatic Urethral Lift opens the prostatic urethra with UroLift (NeoTract Inc., Pleasanton, CA, USA) permanent implants that are delivered under cystoscopic visualization. The implants literally "hold open" the lateral prostatic lobes creating a passage through the obstructed prostatic urethra. Voiding and symptoms are significantly improved without the morbidity or possible complications following prostate resection. The entire procedure can be readily performed using local anesthesia. As with all new implant procedures, the technique has evolved with experience. The objective of this article is to describe the most current technique for the delivery of the UroLift implant in order to achieve maximal impact on symptom relief.
Written by:
Barkin J, Giddens J, Incze P, Casey R, Richardson S, Gange S. Are you the author?
Humber River Regional Hospital, University of Toronto, Toronto, Ontario, Canada.
Reference: Can J Urol. 2012 Apr;19(2):6217-22.
PubMed Abstract
PMID: 22512970
